Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (1-10 of 474) with videos related to

Pageof 48
Sort By:
BJU International|November 7, 2015
Are men who are biopsied without prior prostate magnetic resonance imaging getting substandard care?Mark Emberton
BJU International|January 14, 2012
Contemporary practice, however, bears little resemblance to those fi rst treated cases. ForewordMark Emberton
BJU International|August 30, 2012
Editorial comment: Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomesMark Emberton
European Urology|July 13, 2013
Has magnetic resonance-guided biopsy of the prostate become the standard of care?Mark Emberton
BJU International|July 25, 2013
Are we ready for the new wave of focal therapy interventions for men with early prostate cancer?Mark Emberton
European Urology|March 12, 2014
Is prostate magnetic resonance imaging going to break the bank?Mark Emberton
BJU International|December 18, 2015
Doubling our precision of risk stratification in early prostate cancer: too good to be true?Mark Emberton
Minerva Urology and Nephrology|March 3, 2023
Comment on: "A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMri"Mark Emberton
European Urology|April 7, 2012
Tissue preservation may offer a harm-reduction strategy for men with early prostate cancerMark Emberton
BJU International|March 21, 2017
An end to the phenomenon of 'upgrading' in early prostate cancer?Mark Emberton
Pageof 48

Showing results (1-10 of 474) with videos related to

Sort By:
Pageof 48
BJU International|November 7, 2015
Are men who are biopsied without prior prostate magnetic resonance imaging getting substandard care?Mark Emberton
BJU International|January 14, 2012
Contemporary practice, however, bears little resemblance to those fi rst treated cases. ForewordMark Emberton
BJU International|August 30, 2012
Editorial comment: Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomesMark Emberton
European Urology|July 13, 2013
Has magnetic resonance-guided biopsy of the prostate become the standard of care?Mark Emberton
BJU International|July 25, 2013
Are we ready for the new wave of focal therapy interventions for men with early prostate cancer?Mark Emberton
European Urology|March 12, 2014
Is prostate magnetic resonance imaging going to break the bank?Mark Emberton
BJU International|December 18, 2015
Doubling our precision of risk stratification in early prostate cancer: too good to be true?Mark Emberton
Minerva Urology and Nephrology|March 3, 2023
Comment on: "A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMri"Mark Emberton
European Urology|April 7, 2012
Tissue preservation may offer a harm-reduction strategy for men with early prostate cancerMark Emberton
BJU International|March 21, 2017
An end to the phenomenon of 'upgrading' in early prostate cancer?Mark Emberton
Pageof 48